Oculis Holding AG (OCS) stock
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.39−0.12 (-1.60%)
Close on Nov 18, 2026Market cap $444.06MP/E –Yield –
Oculis cash
Cash and short-term investments held at the end of each period.
Oculis's cash was CHF 61.61M at Jun 30, 2026. For fiscal 2025 it was CHF 81.33M, up 193.5% from the year before. The highest annual figure on record is CHF 81.33M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 81.33M | +193.5% |
| FY2024 | Dec 31, 2024 | CHF 27.71M | -27.7% |
| FY2023 | Dec 31, 2023 | CHF 38.33M | +93.7% |
| FY2022 | Dec 31, 2022 | CHF 19.79M | -57.2% |
| FY2021 | Dec 31, 2021 | CHF 46.28M | +834.5% |
| FY2020 | Dec 31, 2020 | CHF 4.95M | -59.2% |
| FY2019 | Dec 31, 2019 | CHF 12.15M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | CHF 61.61M | +40.5% |
| Q4 FY2025 | Dec 31, 2025 | CHF 81.33M | +112.2% |
| Q2 FY2025 | Jun 30, 2025 | CHF 64.27M | +53.3% |
| Q4 FY2024 | Dec 31, 2024 | CHF 27.71M | +40.0% |
| Q2 FY2024 | Jun 30, 2024 | CHF 43.85M | -5.2% |
| Q4 FY2023 | Dec 31, 2023 | CHF 38.33M | +674.0% |
| Q2 FY2023 | Jun 30, 2023 | CHF 41.93M | +245.1% |
| Q4 FY2022 | Dec 31, 2022 | CHF 19.79M | – |
| Q4 FY2021 | Dec 31, 2021 | CHF 46.28M | – |
| Q4 FY2020 | Dec 31, 2020 | CHF 4.95M | – |
| Q4 FY2019 | Dec 31, 2019 | CHF 12.15M | – |
See a number that looks wrong?